InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,945.95
(
-0.14%
)
US TECH 100
20,328.00
(
0.01%
)
Dow Jones
43,777.93
(
-0.14%
)
Brent Oil
72.60
(
-0.83%
)
Bitcoin
90,120.90
(
-4.38%
)
Post# of 96287
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

zigzagman

Send PM Follow Ignore
Followers 643
Posts 144549
Boards Moderated 1
Alias Born 05/19/2007

zigzagman

Re: Screech691 post# 43514

Wednesday, 09/13/2017 4:13:06 PM

Wednesday, September 13, 2017 4:13:06 PM

Post# of 96287
Protext Pharma to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes

https://finance.yahoo.com/news/protext-pharma-conduct-clinical-trial-141658561.html



TXTM

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED LaFleur Minerals to Restart Gold Milling at Beacon Gold Mill in Val-d'Or, Québec • Mar 3, 2025 10:59 AM

VAYK Proposes 100 million Buyback through Private Repurchases • VAYK • Feb 28, 2025 9:00 AM

ConnectM Eliminates an Additional $1.9 Million of Debt • CNTM • Feb 27, 2025 4:01 PM

Consumer Automotive Finance, Inc. Announces Nationwide Teleconference as It Transitions to Fifty 1 Labs, Inc. • CAFI • Feb 27, 2025 9:00 AM

VPR Brands Secures Settlement Agreement With POP Vapor, Reinforcing Commitment to Intellectual Property Protection • VPRB • Feb 27, 2025 8:49 AM

Wytec Begins Sales of Its Multi-Government AI Threat Detection Sensor Technology • WYTC • Feb 27, 2025 7:05 AM

Start posting your company's news
Only $200 per official company press release!